Art

J-GLOBAL ID：201702289652921883   Reference number：17A0219623

Recent advances in renal cell carcinoma from a pathological point of view

病理的観点からの腎細胞癌の最近の進歩

Author (10)： Mikami Shuji (Division of Diagnostic Pathology, Keio University School of Medicine, Tokyo, Japan) ,  Oya Mototsugu (Department of Urology, Keio University School of Medicine, Tokyo, Japan) ,  Mizuno Ryuichi (Department of Urology, Keio University School of Medicine, Tokyo, Japan) ,  Kosaka Takeo (Department of Urology, Keio University School of Medicine, Tokyo, Japan) ,  Ishida Masaru (Department of Urology, Keio University School of Medicine, Tokyo, Japan) ,  Ishida Masaru (Department of Urology, Saiseikai Tobu Hospital, Yokohama, Japan) ,  Kuroda Naoto (Department of Diagnostic Pathology, Kochi Red Cross Hospital, Kochi, Japan) ,  Nagashima Yoji (Department of Surgical Pathology, Tokyo Women’s Medical University, Tokyo, Japan) ,  Katsube Ken-ichi (Tohto College of Health Science, Saitama, Japan) ,  Okada Yasunori (Department of Pathophysiology for Locomotive and Neoplastic Diseases, Juntendo University Graduate School of Medicine Tokyo, Japan)
Material： Pathology International  (Pathol Int)
Volume： 66  Issue： 9  Page： 481-490  Publication year： Sep. 2016 
JST Material Number： W0853A  ISSN： 1320-5463  Document type： Article
Article type： 文献レビュー  Country of issue： Australia (AUS)  Language： ENGLISH (EN)

Thesaurus term： *renal cell carcinoma ,...
Semi thesaurus term： VEGF ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0219623&from=J-GLOBAL&jstjournalNo=W0853A") }}

Author keywords (5)： cancer stem cell ,  epithelial and mesenchymal transition ,  molecular-targeted therapy ,  renal cell carcinoma ,  resistance

JST classification (3)： Chemistry,biochemistry and pathology of tumors(=neoplasms)  (GE02030N) ,  Urogenital tumors(=neoplasms)  (GM04000S) ,  Research methods in genetics  (EC01020N)

Reference (50)：

• Moch H, Humphrey P, Ulbright TM, Reuter VE. WHO Classification of Tumours of the Urinary System and Male Genital Organs, Fourth edn. Lyon, France: IARC Press, 2016.
• Motzer RJ, Michaelson MD, Redman BG et al. Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma. J Clin Oncol 2006; 24: 16-24.
• Grunert S, Jechlinger M, Beug H. Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat Rev Mol Cell Biol 2003; 4: 657-65.
• Wang SS, Jiang J, Liang XH et al. Links between cancer stem cells and epithelial-mesenchymal transition. Onco Targets Ther 2015; 8: 2973-80.
• Rini BI, Atkins MB. Resistance to targeted therapy in renal-cell carcinoma. Lancet Oncol 2009; 10: 992-1000.

Terms in the title (3)： 病理 ,  観点 ,  腎細胞癌